Metabolites and drug metabolizing enzymes
|
1
|
Metabolism of Strained Rings: Glutathione S-transferase-Catalyzed Formation of a Glutathione-Conjugated Spiro-azetidine without Prior Bioactivation |
Li XQ, Grönberg G, Bangur EH, Hayes MA, Catagnoli Jr. N, Weidolf L |
Drug Metabolism Disposition 47:1247–1256, 2019 |
2
|
Biotransformation of Myricetin: A Novel Metabolic Pathway to Produce Aminated Products in Mice |
Zhang S, Wang R, Zhao Y, Tareq FS, Sang FS |
Molecular Nutrition and Food Research 63(14):1900203, 2019 |
3
|
The Impact of Carboxylesterases in Drug Metabolism and Pharmacokinetics |
Di L |
Current Drug Metabolism 20:91–102, 2019 |
4
|
Biocatalytic Reversal of Advanced Glycation End Product Modification |
Kim NY, Goddard TN, Sohn S, Spiegel DA, Crawford JM |
ChemBioChem 20:2402–2410, 2019 |
5
|
Molecular basis for the P450-catalyzed C–N bond formation in indolactam biosynthesis |
He F, Mori T, Morita I, Nakamura H, Alblova M, Hoshino S, Awakawa T, Abe I |
Nature Chemical Biology 15:1206–1213, 2019 |
6
|
Bioavailability, Biotransformation, and Excretion of the Covalent Bruton Tyrosine Kinase Inhibitor Acalabrutinib in Rats, Dogs, and Humans |
Podoll T, Pearson PG, Evarts J, Ingallinera T, Bibikova E, Sun H, Gohdes M, Cardinal K, Sanghvi M, Slatter JG |
Drug Metabolism Disposition 47:145–154, 2019 |
7
|
Catalytic cleavage of disulfide bonds in small molecules and linkers of antibody- drug conjugates |
Zhang D, Fourie-O’Donohue A, Dragovich PS, Pillow TH, Sadowsky JD, Kozak KR, Cass RT, Liu L, Deng Y, Liu Y, Hop CECA, Khojasteh SC |
Drug Metabolism Disposition 47(10):1156–1163, 2019 |
Bioactivation and Safety
|
8
|
Metabolic Activation of Tofacitinib Mediated by Myeloperoxidase in Vitro |
Guo Y, Jia Y, Han L, Zhao Y, Li W, Zhang Z, Peng Y, Zheng J |
Chemical Research in Toxicology 32:2459–2465, 2019 |
9
|
Definition of Haptens Derived from Sulfamethoxazole: In Vitro and in Vivo |
Tailor A, Waddington J, Hamlett J, Maggs J, Kafu L, Farrell J, Dear G, Whitaker P, Naisbitt D, Park K, Meng X |
Chemical Research in Toxicology 32(10):2095–2106, 2019 |
10
|
Enzalutamide and Apalutamide: In Vitro Chemical Reactivity Studies and Activity in a Mouse Drug Allergy Model |
Ji C, Guha M, Zhu X, Whritenour J, Hemkens M, Tse S, Walker G, Evans E, Khan N, Finkelstein M, Callegari E, Obach R |
Chemical Research in Toxicology 32:2095–2106, 2019 |
11
|
Structure-activity Relationships of CYP4B1 Bioactivation of 4-ipomeanol Congeners: Direct Correlation Between Cytotoxicity and Trapped Reactive Intermediates. |
Kowalski JP, McDonald MG, Whittington D, Guttman M, Scian M, Girhard M, Hanenberg H, Wiek C, Rettie AE |
Chemical Research in Toxicology 32:2488–2498, 2019 |
12
|
A Metabolomic Perspective of Pazopanib-induced Acute Hepatotoxicity in Mice. |
Wang YK, Yang XN, Liang WQ, Xiao Y, Zhao Q, Xiao, Gonzalez FJ, Li F |
Xenobiotica 49(6):655–670, 2019 |
13
|
Rotenone Increases Isoniazid Toxicity but Does Not Cause Significant Liver Injury: Implications for the Hypothesis that Inhibition of the Mitochondrial Electron Transport Chain Is a Common Mechanism of Idiosyncratic Drug-Induced Liver Injury |
Cho T, Wang X, Uetrecht J |
Chemical Research in Toxicology 32:1423–1431, 2019 |
14
|
Mechanism of Idiosyncratic Drug-Induced Liver Injury Quantitative Evaluation of Reactivity and Toxicity of Acyl Glucuronides by [35S]-Cysteine Trapping |
Harada H, Toyoda Y, Abe Y, Endo T, Takeda H |
Chemical Research in Toxicology 32:1955–1964, 2019 |